Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS. - Wikidata - awgldk - TriplyDB

Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS.

Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS.

http://www.wikidata.org/entity/Q30395380

about

Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus.

P2860

Q41708805-1C84E447-875D-45AA-B600-AE9533492D51 Q51556981-588962DC-97E8-4588-A646-9F328B007079

P2860

Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS.

http://www.wikidata.org/entity/Q30395380

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Screening for potential serum- ...... s mellitus using MALDI-TOF MS.

@ast

Screening for potential serum- ...... s mellitus using MALDI-TOF MS.

@en

type

label

Screening for potential serum- ...... s mellitus using MALDI-TOF MS.

@ast

Screening for potential serum- ...... s mellitus using MALDI-TOF MS.

@en

prefLabel

Screening for potential serum- ...... s mellitus using MALDI-TOF MS.

@ast

Screening for potential serum- ...... s mellitus using MALDI-TOF MS.

@en

P1433

Q30395380-10E7AB6A-F870-443A-9AE2-E3DB997D944A

P1476

Q30395380-99C2E79D-BEBD-4C36-A94A-7530AA5CA300

P2093

Q30395380-0CBD0F13-420D-4F40-B1CE-70FEC23D1B09

Q30395380-12E6AA17-B5C3-4257-99D3-983E7F6E6B1F

Q30395380-1A7109D7-F8F2-4C7F-93BB-119AB1141C17

Q30395380-3C7E3C8C-4650-4E34-BA99-1E12E7D939BA

Q30395380-3FDBB3DE-C383-4E88-95C4-57E4B7C019A0

Q30395380-4403E04C-5A75-4564-8F01-F504997105F7

Q30395380-45DC9070-AD3B-44CD-8A0A-8FB7346217EB

Q30395380-4F2010D3-43BE-4E6C-B8E0-1DFD6D4F6E33

Q30395380-57B36983-F941-4856-AEEB-016D1C2622F0

Q30395380-5A472649-56F6-4E7F-A8CD-A404BAFBFF0F

P2860

Q30395380-0B9DEC6C-4FE7-4E36-9DAF-68477B5DB1D7

Q30395380-0E03C24D-C40F-40BD-94B5-F92AD8C1E24B

Q30395380-14E91F74-2E84-4590-9718-1C84CE9931FD

Q30395380-1A960686-BA0B-4AC6-AD53-EF85BB778390

Q30395380-2296F1BE-91E0-4808-8572-B0AB406DD4A5

Q30395380-23F29790-FC79-425F-B14D-4043C5F59BEB

Q30395380-27778D5E-9097-4A44-885A-0BF24E04443C

Q30395380-2A14CBC0-0A23-437A-A5E0-BF9FEFF9F3C1

Q30395380-2B69F85B-0B46-42E0-9ABD-CBBD9F1AE85E

Q30395380-40D7E9D6-64C4-4978-B19F-95C36C8DC595

P31

Q30395380-5475F036-19BC-4202-841F-74B258A2F429

P356

Q30395380-AD4CB7A2-7181-4DDF-A8D6-6EE516D39DDD

P433

Q30395380-6691CF58-4588-4CE0-9E29-96868C230D44

P478

Q30395380-E496AFD4-6077-494F-A85B-3929D7436269

P50

Q30395380-12A31B9C-FA9D-4D8A-9DDE-BB85C573E8E7

Q30395380-396EB66B-42AD-4F16-B89F-543F8FE74FE1

P577

Q30395380-84152E78-9527-4C1A-9EBF-488ACD87C538

P698

Q30395380-F0CB4BFF-B4E5-4C2E-A43D-906BC35886FC

P921

Q30395380-62EE99E0-3B55-472C-929A-D93EA2A6F70D

Q30395380-E5ED5E7D-7EBE-4EE9-91EF-8FEA37D8BA35

P356

P1433

Proteomics - Clinical Applications

P1476

Screening for potential serum- ...... es mellitus using MALDI-TOF MS

@en

P2093

Baoan Wang

http://www.w3.org/2001/XMLSchema#string

Desmond Menon

http://www.w3.org/2001/XMLSchema#string

Feifei Zhao

http://www.w3.org/2001/XMLSchema#string

Fen Liu

http://www.w3.org/2001/XMLSchema#string

Feng Chen

http://www.w3.org/2001/XMLSchema#string

Haibing Wang

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Jingtao Dou

http://www.w3.org/2001/XMLSchema#string

Lijuan Wu

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for engagement by complement factor H of C3b on a self surface

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Metabolite profiles and the risk of developing diabetes

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.

The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.

Plasma proteomic pattern as biomarkers for ovarian cancer.

Localized-statistical quantification of human serum proteome associated with type 2 diabetes

Optimization of magnetic beads for maldi-TOF MS analysis.

MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.

P31

scholarly article

P356

10.1002/PRCA.201600079

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Mohamed Ali Alzain

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27863080

http://www.w3.org/2001/XMLSchema#string

P921

matrix-assisted laser desorption/ionization